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Summary: Semen specimens from four groups of patients were evaluated for coagulation and fibrinolysis
factors:
a group of patients with infertile semen and involuntary childlessness (n = 35),
a group with fertile semen and involuntary childlessness (n = 39),
a group with fertile semen and proven fertility before vasectomy (n = 34) and
a group with infertile semen after vasectomy (n = 147).
The third patient group with proven fertility before vasectomy was considered as a control group. Only small
amounts of fibrinogen, factor VIII:c, plasminogen, antithrombin III, fibrin monomers and plasminogen
activator inhibitor-1 were detected in seminal plasma. The thrombin-antithrombin HI, D-dimer and tissue
plasminogen activator regular concentrations were measured and the D-dimer/thrombin-antithrombin III
ratios calculated. The reference ranges were assessed and the quantities were compared in the different patient
groups. Significant differences were demonstrated between the prevasectomy group (= control group) and
both the postvasectomy and the infertility groups with respect to D-dimer and D-dimer/thrombin-antithrombin
III ratio. We conclude that both coagulation and fibrinolysis play a part in coagulum formation and
liquefaction of seminal plasma. The balance between coagulation and fibrinolysis (expressed as D-dimer/
thrombin-antithrombin III ratio) was significantly different between the control group and the three patient
groups. The coagulation/fibrinolysis balance was impaired in the semen from post vasectomy patients and
from those with involuntary childlessness and the D-dimer/thrombin-antithrombin HI -ratios in both these
patient groups were very similar.
Introduction ,A _, T , , A , - - , ~(4, 5). It has been suggested that the degree of coag-
Immediately after ejaculation, semen is coagulated ulation of ejaculated semen may be correlated with
and liquefaction takes 5 to 20 minutes (1). The clotting epididymal function (3) and that subfertility may be
process is induced by the enzyme vasiculase original·· associated with poor coagulation caused by a lower
ing from the prostate gland. The coagulum consists osmolality and buffering capacity and a higher pH
of a fibrin-like material, which is considered to be than samples showing good coagulation (6). The aim
composed of sialo-glycoprotein-metal complexes (2) of the study was to assess if the fibrin-like coagulum
and of glycerylphosphorylcholine (3). The high mo- contained (or had contained) fibrin by measuring
lecular weight seminal vesicle protein is degraded by coagulation activation and fibrinolysis products in the
proteases of the prostatic fluid when the clot liquefies seminal plasma after liquefaction, and to establish
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reference ranges in normal seminal plasmas. Finally
the measured quantities were compared in involun-
tarily childless and normal males. The relevant part




Fibrinogen was measured with a clotting assay (Merz and
Dade) according to the method of Clauss, by means of a
Schnitger and Gross coagulometer. Factor VIIIic was deter-
mined in a one stage clotting assay with the aid of a F VIII
deficient plasma of Behring (Marburg, Germany). Antithrom-
bin III was assessed with a chromogenic substrate method of
the Behring Corporation (Germany). The chromogenic Coa set
FM test of Kabi Vitrum Diagnostica (M lndal, Sweden) was
used for the fibrin monomer determinations. The thrombin-
antithrombin III was determined using an ELISA test kit from
Behring (Behring Marburg, Germany). The fibrin degradation
products were measured by means of the D-dimer test (Boeh-
ringer Mannheim, Mannheim, Germany). The D-dimer test is
a specific ELISA test for the determination of degradation
products of cross-linked fibrin only and not of fibrinogen.
Plasminogen activator inhibitor-1 and tissue plasminogen ac-
tivator activity were quantitated by measuring the enzymatic
activity of the plasmin generated in the test procedure in the
presence of fibrinogen fragments against the synthetic substrate
S-2251 (Kabi Vitrum Diagnostica).
Precision of the methods
For thrombin-antithrombin III the intra-assay and inter-assay
coefficient of variation were 5.1% and 7.4% respectively. The
D-dimer analysis showed a intra-assay coefficient of variation
of 7.1% and an inter-assay coefficient of variation of 10.0%.
The coefficients of variation obtained for the tissue plasminogen
activator activity assay were 6.2% for the intra-assay variation
and 10.1% for the inter-assay variation.
Samples
The semen was obtained at home after masturbation and was
collected in graduated tubes. The material had to be presented
in the laboratory whithin one hour of production. The semen
was centrifuged after liquefaction (2000 g at room temperature,
10 min) and the seminal plasma collected. The supernatant was
deep frozen at — 70 °C until the next batch of measurements.
Patients
Quantities associated with coagulation and fibrinolysis were
investigated in the seminal plasma of 255 patients. The patients
under evaluation for infertility were subdivided into two groups:
group I (n = 35) consisted of men with infertile semen accord-
ing to the sperm concentration and motility and group II
(n = 39) of men with fertile semen according to the sperm
concentration and motility, but without proven fertility. It is
considered to be normal if the sperm concentration is > 20
χ 109/1 and the progressive motility is > 30% (7). The seminal
plasma for male individuals with proven fertility, who came to
the urology clinic for vasectomy (group III, n = 34), was used
as a positive control group; the seminal plasma of a group of
vasectomized patients (group IV, n = 147) was used as a neg-
ative control group. All the patients underwent urological ex-
amination for the exclusion of anatomical, infectious and en-
docrinological abnormalities. In the group of males attending
the clinic for assessment because of a marriage with delayed



























Fig. 1. Relevant part of the coagulation and fibrinolysis cas-
cade
Statistical analysis
The Mann-Whitney-Wilcoxon test was employed for the com-
parison of the patient groups with each other and of the patient
groups with the reference group.
Results
As can be seen in table 1, measurable quantities of
fibrinogen, plasminogen, plasminogen activator in-
hibitor-1, factor VIH:c and fibrin monomers could
not be detected, and the antithrombin III level was
low (0.2-0.6%).
In table 2 the reference ranges for the relevant quan-
tities in blood plasma are given.
Table 3 summarizes the data on the volume, sper-
matozoa count, thrombin-antithrombin-III, D-dimer,
D-dimer/thrombin-antithrombin III ratio, tissue plas-
minogen activator activity and the percentage of pro-
pulsively moving spermatozoa for the prevasectomy
and postvasectomy groups as well as for the infertility
groups. The mean values of the patient groups I and
II were compared with the control group III and the
postvasectomy group. Significant differences were
found between group I and control group III for the
D-dimer/thrombin-antithrombin III ratio (p = 0.004)
and the D-dimer level (p = 0.033). Significant differ-
ences between group II and III were found for D-
dimer (p = 0.007) and the D-dimer/thrombin-antith-
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 30,1992 / No. 8
Van Wersch et al.: Coagulation and fibrinolysis markers in seminal plasma 469






Plasminogen activator inhibitor- 1
Fibrin monomer










0-4.6 χ 103 AU/1
8.4 -13.2 nmol/1
Tab. 2. Reference ranges of the relevant quantities in blood











') mean ± 2 SD
2) 0th to 95th percentile
rombin III ratio (p = 0.02). There were no significant
differences between the vasectomized patients and
group III, nor could any significant difference be
found between groups I and IV or II and IV. Signif-
icant differences were found for the D-dimer levels
and D-dimer/thrombin-antithrombin III ratios be-
tween the postvasectomy group IV and the prevasec-
tomy patient group III (p-values 0.026 and 0.0008,
respectively).
Discussion
The presence of the coagulation and fibrinolysis
markers thrombin-antithrombin III and D-dimer, to-
gether with the extremely high tissue plasminogen
activator levels (in comparison with the blood plasma
concentrations), is an indication that they have a
function in semen and that the seminal coagulum is
at least partly composed of fibrin. It seems that the
low antithrombin III concentration (600—1800 μg/l)
is high enough for the thrombin-antithrombin III
complex formation in the concentrations measured in
this study. We could not measure directly the presence
of prothrombin but in the meantime we found con-
siderable amounts of prothrombin fragment 1.2 in the
seminal plasma (still unpublished data). This is indi-
rect evidence for the presence of the prothrombin
needed for fibrin production. Fibrin once formed is
known to provoke fibrinolysis by stimulating tissue
Tab. 3. Summary of the results in the different groups. The significance levels were:
') I vs III ρ = 0.033, 2) II vs III ρ = 0.007, 3) IV vs III ρ = 0.026, 4) I vs III ρ = 0.004, 5) II vs III ρ = 0.02,
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plasminogen activator activity, which actually has
been shown to be present in very high concentrations
(9). The final result is then the formation of D-dimers.
The presence of plasminogen activator was demon-
strated long ago by Suominen & Niemi (8), but no
plasmin-like proteinase activity was found. Very re-
cently the presence of high tissue plasminogen acti-
vator antigen has been reported again by Maier et al.
(10) both in spermatozoa and in seminal plasma.
Little is known about the role of tissue plasminogen
activator activity. But it might prevent the occlusion
of tubular structures in the urogenital tract.
The D-dimer fragments as degradation products can
only originate from previously formed cross-linked
fibrin. Evidence for cross-linking activity has been
found with the demonstration of transglutaminase
secretion through the anterior prostate in guinea pigs
(11) and rats (12). Transglutaminase or factor XIII
activity, however, has not so far been detected in
human semen (5, 13), although our results suggest
such an activity. The initiation of coagulation acti-
vation might be partly explained by the presence of
prostate-specific antigen, which is believed to be a
kallikrein-like serine protease in prostatic fluid, which
cleaves the predominant seminal vesical protein (14).
It is well known that kallikrein is one of the activators
of the intrinsic pathway of the clotting cascade.
Moreover Minhas et al. (15) have reported the pres-
ence of platelet-activating factor-like activity in hu-
man spermatozoa. Platelet-activating factor is a po-
tent phospholipid with a wide spectrum of biological
activities (16) which might induce activation of co-
agulation. Moreover Sugkraroek et al. (17) discussed
the role of different levels of cholesterol and phos-
pholipids in sperm from fertile and interfertile men.
The presence of coagulation factors in seminal plasma
need no longer be considered a strange phenomenon
since Laurell et al. (18) recently reported the presence
of very high concentrations (220 mg/1) of protein C
inhibitor with a relative molecular mass of
MT = 57 000 in seminal plasma. These concentrations
are very high as compared with 5.3 mg/1 in blood
plasma. They demonstrated the local production of
protein C inhibitor in the male sex glands and the
secretory origin in the seminal vesicles. Significantly
lower values for D-dimer and D-dimer/thrombin-an-
tithrombin III ratios were found in all groups of
patients with infertility or after vasectomy in com-
parison with the control group. The D-dimer/throm-
bin-antithrombin III ratio can be seen as an indicator
of the balance between fibrinolysis and coagulation.
The decreased D-dimer/thrombin-antithrombin III
ratio in both infertile and vasectomized patients sug-
gests a disturbance of that balance, caused either by
a shift towards coagulation activation, or to a reduc-
tion of fibrinolysis, or to both, and it is independent
of the number of spermatozoa previously present. The
D-dimer/thrombin-antithrombin III ratio is reduced
in the infertile group as well as in the postvasectomy
group, in whom no spermatozoa are present.
Groups I and IV show rather high thrombin-anti-
thrombin III values with moderate D-dimer values,
possibly indicating a retardation of the liquefaction
of the coagulum, which might reduce the motility of
the spermatozoa. This confirms a suggestion of Man-
dal et al. (3, 19) that there is a possible relationship
between the coagulum liquefication properties of hu-
man ejaculates and the semen quality and that there
is an association between subfertility and/or coagulum
formation after ejaculation.
Furthermore, the similarity between the D-dimer/
thrombin-antithrombin III ratios in involuntary child-
less patients and in the postvasectomy patients is
remarkable. The present results are an encouragement
for further studies in this field, and they draw atten-
tion to coagulation and fibrinolysis markers in the
evaluation of patients with fertility problems.
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